Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inositol hexakisphosphate and beta-cell stimulus-secretion coupling.

C J Barker1, P O Berggren

  • 1Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden.

Anticancer Research
|January 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pancreatic islet: a micro-organ in control.

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes.

Diabetologia·2011
Same author

Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion.

Cellular and molecular life sciences : CMLS·2007
Same author

Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling.

Bioscience reports·2007
Same author

Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells.

Cellular and molecular life sciences : CMLS·2002
Same author

Short-term regulation of insulin gene transcription.

Biochemical Society transactions·2002
Same journal

Corrigendum.

Anticancer research·2026
Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026
Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026
Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026
Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026
Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026
See all related articles

Inositol hexakisphosphate (InsP6) regulates calcium (Ca2+) influx and insulin secretion by inhibiting protein phosphatases in pancreatic cells. This molecule plays a key role in modulating insulin exocytosis and granule recruitment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Inositol hexakisphosphate (InsP6) is a molecule known to interact with cellular processes.
  • Serine/threonine protein phosphatases (PP1, PP2A, PP3) regulate various cellular functions, including ion channel activity and exocytosis.
  • Voltage-gated L-type Ca(2+)-channels are crucial for insulin secretion.

Purpose of the Study:

  • To investigate the role of InsP6 in modulating Ca(2+)-channel activity and insulin exocytosis.
  • To elucidate the mechanisms by which InsP6 influences insulin secretion in pancreatic beta-cells.

Main Methods:

  • In vitro assays measuring protein phosphatase inhibition by InsP6.
  • Electrophysiological studies to assess Ca(2+)-channel activity in the presence of InsP6.

Related Experiment Videos

  • Experiments measuring insulin secretion from permeabilized cells stimulated by Ca(2+) and InsP6.

    • Main Results:

    • InsP6 inhibits PP1, PP2A, and PP3 in a concentration-dependent manner.
    • InsP6 increases Ca(2+)-channel activity by inhibiting phosphatases, suggesting a role in regulating Ca(2+) influx.
    • InsP6 modulates insulin exocytosis, stimulating secretion at high concentrations and priming Ca(2+)-induced secretion at lower concentrations, mediated by Protein Kinase C (PKC) activation.

    Conclusions:

    • InsP6 is a key regulator of Ca(2+) influx in insulin-secreting cells.
    • InsP6 plays a significant modulatory role in insulin exocytosis, potentially by recruiting secretory granules.
    • The membrane localization and rapid turnover of InsP6 suggest novel functions in the insulin secretory process.